Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 01 2021
Historique:
received: 23 01 2020
accepted: 22 09 2020
entrez: 6 1 2021
pubmed: 7 1 2021
medline: 13 1 2021
Statut: epublish

Résumé

Differences between sexes contribute to variation in the levels of fasting glucose and insulin. Epidemiological studies established a higher prevalence of impaired fasting glucose in men and impaired glucose tolerance in women, however, the genetic component underlying this phenomenon is not established. We assess sex-dimorphic (73,089/50,404 women and 67,506/47,806 men) and sex-combined (151,188/105,056 individuals) fasting glucose/fasting insulin genetic effects via genome-wide association study meta-analyses in individuals of European descent without diabetes. Here we report sex dimorphism in allelic effects on fasting insulin at IRS1 and ZNF12 loci, the latter showing higher RNA expression in whole blood in women compared to men. We also observe sex-homogeneous effects on fasting glucose at seven novel loci. Fasting insulin in women shows stronger genetic correlations than in men with waist-to-hip ratio and anorexia nervosa. Furthermore, waist-to-hip ratio is causally related to insulin resistance in women, but not in men. These results position dissection of metabolic and glycemic health sex dimorphism as a steppingstone for understanding differences in genetic effects between women and men in related phenotypes.

Identifiants

pubmed: 33402679
doi: 10.1038/s41467-020-19366-9
pii: 10.1038/s41467-020-19366-9
pmc: PMC7785747
doi:

Substances chimiques

Blood Glucose 0
IRS1 protein, human 0
Insulin 0
Insulin Receptor Substrate Proteins 0
Kruppel-Like Transcription Factors 0
ZNF12 protein, human 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Subventions

Organisme : Medical Research Council
ID : G0600705
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK078616
Pays : United States
Organisme : Wellcome Trust
ID : 098381
Pays : United Kingdom
Organisme : NCRR NIH HHS
ID : UL1 RR033176
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100012C
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089951
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD028138
Pays : United States
Organisme : Wellcome Trust
ID : 083948
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100009I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH063706
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011-1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 217065/Z/19/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL075366
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : ZIA HG000024
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR046838
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH081802
Pays : United States
Organisme : NHGRI NIH HHS
ID : N01HG65403
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL036310
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100010C
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025005
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG015928
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062101
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087679
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089995
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005G
Pays : United States
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100008I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059367
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087660
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007C
Pays : United States
Organisme : EPA
ID : EP-C-15-001
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01 HC015103
Pays : United States
Organisme : Wellcome Trust
ID : GR069224
Pays : United Kingdom
Organisme : NIMHD NIH HHS
ID : R01 MD009164
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054464
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004171
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG020098
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK072193
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL086694
Pays : United States
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : R01 HG000376
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG008724
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085475/B/08/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL087652
Pays : United States
Organisme : Wellcome Trust
ID : 092447/Z/10/Z
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG004402
Pays : United States
Organisme : Wellcome Trust
ID : WT098017
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062106
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : Department of Health
ID : NF-SI-0617-10090
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106130
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : U01 HL054464
Pays : United States
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L020149/1
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NHLBI NIH HHS
ID : N02 HL64278
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL119443
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK105535
Pays : United States
Organisme : NIDA NIH HHS
ID : R37 DA018673
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG032098
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062370
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : NIA NIH HHS
ID : N01AG12100
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH058799
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG013196
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054457
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12015/2
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG028555
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054481
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK063491
Pays : United States
Organisme : NHGRI NIH HHS
ID : HHSN268200782096C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100006C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : Wellcome Trust
ID : 084727/Z/08/Z
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL054457
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062103
Pays : United States
Organisme : Wellcome Trust
ID : WT205915
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM010098
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK080140
Pays : United States
Organisme : NIMH NIH HHS
ID : U24 MH068457
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072515
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : G20234
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201543/B/16/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL080295
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK078616
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : Wellcome Trust
ID : 212259
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : U01 DK062370
Pays : United States
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0500539
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG020098
Pays : United States
Organisme : Wellcome Trust
ID : 090532/Z/09/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC75150
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG013196
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA018673
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH090941
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL054481
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007I
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK092127
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : N01AG50002
Pays : United States
Organisme : NIMH NIH HHS
ID : RL1 MH083268
Pays : United States
Organisme : NIDDK NIH HHS
ID : UM1 DK078616
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR055688
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087641
Pays : United States
Organisme : Wellcome Trust
ID : 202802/Z/16/Z
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG027058
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01 HC045133
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG010175
Pays : United States
Organisme : NIDA NIH HHS
ID : HHSN271201200022C
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG018728
Pays : United States
Organisme : Wellcome Trust
ID : 085475/Z/08/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01 HC035129
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG023629
Pays : United States
Organisme : British Heart Foundation
ID : PG/07/133/24260
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH101814
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Faerch, K., Borch-Johnsen, K., Vaag, A., Jorgensen, T. & Witte, D. R. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53, 858–865 (2010).
pubmed: 20182862 doi: 10.1007/s00125-010-1673-4
Perreault, L. et al. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 31, 1416–1421 (2008).
pubmed: 18356403 pmcid: 2453677 doi: 10.2337/dc07-2390
Rathmann, W., Strassburger, K., Giani, G., Doring, A. & Meisinger, C. Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabet. Med. 25, 1374–1375 (2008).
pubmed: 19046233
Tramunt, B. et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63, 453–461 (2020).
pubmed: 31754750 doi: 10.1007/s00125-019-05040-3
Kautzky-Willer, A., Harreiter, J. & Pacini, G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr. Rev. 37, 278–316 (2016).
pubmed: 27159875 pmcid: 4890267 doi: 10.1210/er.2015-1137
Marullo, L., El-Sayed Moustafa, J. S. & Prokopenko, I. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. Curr. Diabetes Rep. 14, 551 (2014).
doi: 10.1007/s11892-014-0551-8
Horikoshi, M. et al. Discovery and fine-mapping of glycaemic and obesity-related trait loci using high-density imputation. PLoS Genet. 11, e1005230 (2015).
pubmed: 26132169 pmcid: 4488845 doi: 10.1371/journal.pgen.1005230
Randall, J. C. et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 9, e1003500 (2013).
pubmed: 23754948 pmcid: 3674993 doi: 10.1371/journal.pgen.1003500
Heid, I. M. et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949–960 (2010).
pubmed: 20935629 pmcid: 3000924 doi: 10.1038/ng.685
Kilpelainen, T. O. et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753–760 (2011).
pubmed: 21706003 pmcid: 3262230 doi: 10.1038/ng.866
Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015).
pubmed: 25673412 pmcid: 4338562 doi: 10.1038/nature14132
Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981–990 (2012).
pubmed: 22885922 pmcid: 3442244 doi: 10.1038/ng.2383
Sandholm, N. et al. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J. Am. Soc. Nephrol. 24, 1537–1543 (2013).
pubmed: 24029427 pmcid: 3785274 doi: 10.1681/ASN.2012111122
Magi, R., Lindgren, C. M. & Morris, A. P. Meta-analysis of sex-specific genome-wide association studies. Genet Epidemiol. 34, 846–853 (2010).
pubmed: 21104887 pmcid: 3410525 doi: 10.1002/gepi.20540
Magi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinforma. 11, 288 (2010).
doi: 10.1186/1471-2105-11-288
International HapMap, C. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
doi: 10.1038/nature04226
Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 8, e1002793 (2012).
pubmed: 22876189 pmcid: 3410907 doi: 10.1371/journal.pgen.1002793
Rueger, S., McDaid, A. & Kutalik, Z. Evaluation and application of summary statistic imputation to discover new height-associated loci. PLoS Genet. 14, e1007371 (2018).
pubmed: 29782485 pmcid: 5983877 doi: 10.1371/journal.pgen.1007371
Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466, 707–713 (2010).
pubmed: 20686565 pmcid: 3039276 doi: 10.1038/nature09270
Scott, R. A. et al. An expanded genome-wide association study of type 2. Diabetes Eur. Diabetes 66, 2888–2902 (2017).
Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659 (2012).
pubmed: 22581228 pmcid: 3613127 doi: 10.1038/ng.2274
Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991–1005 (2012).
pubmed: 22885924 pmcid: 3433394 doi: 10.1038/ng.2385
Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166–174 (2019).
pubmed: 30239722 doi: 10.1093/hmg/ddy327
Replication, D. I. G. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234–244 (2014).
doi: 10.1038/ng.2897
Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579–589 (2010).
pubmed: 20581827 pmcid: 3080658 doi: 10.1038/ng.609
Yang, T. T. et al. Role of transcription factor NFAT in glucose and insulin homeostasis. Mol. Cell Biol. 26, 7372–7387 (2006).
pubmed: 16908540 pmcid: 1636854 doi: 10.1128/MCB.00580-06
Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 12, 159–169 (2012).
pubmed: 22337149 doi: 10.1038/nrc3215
Ekyalongo, R. C. & Yee, D. Revisiting the IGF-1R as a breast cancer target. npj Precis. Oncol. 1, 14 (2017).
pubmed: 29152592 pmcid: 5687252 doi: 10.1038/s41698-017-0017-y
Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
doi: 10.1038/nature13595
Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
pubmed: 24097068 pmcid: 3838666 doi: 10.1038/ng.2797
International Multiple Sclerosis Genetics, C. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214–219 (2011).
doi: 10.1038/nature10251
Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
pubmed: 23128233 pmcid: 3491803 doi: 10.1038/nature11582
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, S1–S3 (2012). 369-75.
doi: 10.1038/ng.2213
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363 doi: 10.1016/j.ajhg.2010.11.011
Fall, T. et al. Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes 64, 1841–1852 (2015).
pubmed: 25712996 pmcid: 4407863 doi: 10.2337/db14-0988
Jansen, R. et al. Gene expression in major depressive disorder. Mol. Psychiatry 21, 339–347 (2016).
pubmed: 26008736 doi: 10.1038/mp.2015.57
Min, J. L. et al. Coexpression network analysis in abdominal and gluteal adipose tissue reveals regulatory genetic loci for metabolic syndrome and related phenotypes. PLoS Genet. 8, e1002505 (2012).
pubmed: 22383892 pmcid: 3285582 doi: 10.1371/journal.pgen.1002505
Dimas, A. S. et al. Sex-biased genetic effects on gene regulation in humans. Genome Res. 22, 2368–2375 (2012).
pubmed: 22960374 pmcid: 3514666 doi: 10.1101/gr.134981.111
Gertow, K. et al. Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ. Cardiovasc Genet. 5, 656–665 (2012).
pubmed: 23152477 doi: 10.1161/CIRCGENETICS.112.963660
Fadista, J. et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc. Natl Acad. Sci. USA 111, 13924–13929 (2014).
pubmed: 25201977 pmcid: 4183326 doi: 10.1073/pnas.1402665111
Nica, A. C. et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
pubmed: 21304890 pmcid: 3033383 doi: 10.1371/journal.pgen.1002003
Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
doi: 10.1038/ng.2653
Shimoyama, M. et al. The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease. Nucleic Acids Res. 43, D743–D750 (2015).
pubmed: 25355511 doi: 10.1093/nar/gku1026
Meyer, M. et al. A high-coverage genome sequence from an archaic Denisovan individual. Science 338, 222–226 (2012).
pubmed: 22936568 pmcid: 3617501 doi: 10.1126/science.1224344
The, S.T.D.C. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506, 97 (2013).
Goldfine, A. B. et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern Med. 159, 1–12 (2013).
pubmed: 23817699 pmcid: 4128629 doi: 10.7326/0003-4819-159-1-201307020-00003
Warren, M. P. Endocrine manifestations of eating disorders. J. Clin. Endocrinol. Metab. 96, 333–343 (2011).
pubmed: 21159848 doi: 10.1210/jc.2009-2304
Festa, A. et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53, 1549–1555 (2004).
pubmed: 15161760 doi: 10.2337/diabetes.53.6.1549
D’Orazio, P. et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin. Chem. 51, 1573–1576 (2005).
pubmed: 16120945 doi: 10.1373/clinchem.2005.051979
Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105–116 (2010).
pubmed: 20081858 pmcid: 3018764 doi: 10.1038/ng.520
Prokopenko, I. et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 41, 77–81 (2009).
pubmed: 19060907 doi: 10.1038/ng.290
Li, Y., Willer, C., Sanna, S. & Abecasis, G. Genotype imputation. Annu. Rev. Genom. Hum. Genet. 10, 387–406 (2009).
doi: 10.1146/annurev.genom.9.081307.164242
Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).
pubmed: 21058334 pmcid: 3175618 doi: 10.1002/gepi.20533
Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
pubmed: 19543373 pmcid: 2689936 doi: 10.1371/journal.pgen.1000529
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
pubmed: 17572673 doi: 10.1038/ng2088
Browning, B. L. & Browning, S. R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84, 210–223 (2009).
pubmed: 19200528 pmcid: 2668004 doi: 10.1016/j.ajhg.2009.01.005
Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Rüeger, S., McDaid, A. & Kutalik, Z. Improved imputation of summary statistics for admixed populations. https://www.biorxiv.org/content/10.1101/203927v3 (2018).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
pubmed: 11315092 doi: 10.1111/j.0006-341X.1999.00997.x
Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).
pubmed: 27663502 doi: 10.1093/bioinformatics/btw613
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Haycock, P. C. et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am. J. Clin. Nutr. 103, 965–978 (2016).
pubmed: 26961927 pmcid: 4807699 doi: 10.3945/ajcn.115.118216
Pierce, B. L. & Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am. J. Epidemiol. 178, 1177–1184 (2013).
pubmed: 23863760 pmcid: 3783091 doi: 10.1093/aje/kwt084
Burgess, S. et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 4, 186 (2019).
pubmed: 32760811 doi: 10.12688/wellcomeopenres.15555.1
Burgess, S. et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543–552 (2015).
pubmed: 25773750 pmcid: 4516908 doi: 10.1007/s10654-015-0011-z
Zheng, J. et al. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 4, 330–345 (2017).
pubmed: 29226067 pmcid: 5711966 doi: 10.1007/s40471-017-0128-6
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
pubmed: 26050253 pmcid: 4469799 doi: 10.1093/ije/dyv080
Lukowiak, B. et al. Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J. Histochem. Cytochem. 49, 519–528 (2001).
pubmed: 11259455 doi: 10.1177/002215540104900412
Taneera, J. et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 16, 122–134 (2012).
pubmed: 22768844 doi: 10.1016/j.cmet.2012.06.006
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
pubmed: 19289445 pmcid: 2672628 doi: 10.1093/bioinformatics/btp120
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
pubmed: 19261174 pmcid: 2690996 doi: 10.1186/gb-2009-10-3-r25
Anders, S., Reyes, A. & Huber, W. Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008–2017 (2012).
pubmed: 22722343 pmcid: 3460195 doi: 10.1101/gr.133744.111
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
pubmed: 20196867 pmcid: 2864565 doi: 10.1186/gb-2010-11-3-r25
Roberts, A., Pimentel, H., Trapnell, C. & Pachter, L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27, 2325–2329 (2011).
pubmed: 21697122 doi: 10.1093/bioinformatics/btr355
Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012).
pubmed: 22955987 pmcid: 3431492 doi: 10.1101/gr.135350.111
Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res. 41, e74 (2013).
pubmed: 23335781 pmcid: 3616698 doi: 10.1093/nar/gkt006
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648 pmcid: 3348564 doi: 10.1093/bioinformatics/bts163
Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181 (2012).
doi: 10.1038/nmeth.1785
Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005).
pubmed: 16284200 pmcid: 1283542 doi: 10.1093/nar/gni179
Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
pubmed: 12925520 doi: 10.1093/biostatistics/4.2.249
Iotchkova, V. et al. Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps. Nat. Genet. 48, 1303–1312 (2016).
pubmed: 27668658 pmcid: 5279872 doi: 10.1038/ng.3668
Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002).
pubmed: 12111919 doi: 10.1002/sim.1186

Auteurs

Vasiliki Lagou (V)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Department of Microbiology and Immunology, Laboratory of Adaptive Immunity, KU Leuven, Leuven, Belgium.
VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.

Reedik Mägi (R)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Jouke- Jan Hottenga (JJ)

Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, VU University medical center, Amsterdam, the Netherlands.

Harald Grallert (H)

Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.
German Center for Diabetes Research (DZD, München-Neuherberg, Germany.

John R B Perry (JRB)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Nabila Bouatia-Naji (N)

University of Lille Nord de France, Lille, France.
CNRS UMR8199, Institut Pasteur de Lille, Lille, France.
INSERM U970, Paris Cardiovascular Research Center PARCC, 75006, Paris, France.

Letizia Marullo (L)

Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.

Denis Rybin (D)

Boston University Data Coordinating Center, Boston, MA, USA.

Rick Jansen (R)

Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.

Josine L Min (JL)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Antigone S Dimas (AS)

Institute for Bioinnovation, Biomedical Sciences Research Center Al. Fleming, Vari, Greece.

Anna Ulrich (A)

Department of Medicine, Imperial College London, London, UK.

Liudmila Zudina (L)

Department of Medicine, Imperial College London, London, UK.

Jesper R Gådin (JR)

Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Karolinska University Hospital, Solna, Sweden.

Longda Jiang (L)

Department of Medicine, Imperial College London, London, UK.
Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Alessia Faggian (A)

Department of Medicine, Imperial College London, London, UK.

Amélie Bonnefond (A)

University of Lille Nord de France, Lille, France.
CNRS UMR8199, Institut Pasteur de Lille, Lille, France.
Department of Medicine, Imperial College London, London, UK.

Joao Fadista (J)

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Maria G Stathopoulou (MG)

Université de Lorraine, IGE-PCV, F-54000, Nancy, France.

Aaron Isaacs (A)

Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
CARIM School for Cardiovascular Diseases and Maastricht Centre for Systems Biology (MaCSBio, Maastricht University, Maastricht, the Netherlands.
Department of Physiology, Maastricht University, Maastricht, the Netherlands.

Sara M Willems (SM)

Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.

Pau Navarro (P)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Toshiko Tanaka (T)

Translational Gerontology Branch, Longitudinal Study Section, National Institute on Aging, Baltimore, MD, USA.

Anne U Jackson (AU)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

May E Montasser (ME)

Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA.

Jeff R O'Connell (JR)

Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA.

Lawrence F Bielak (LF)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Rebecca J Webster (RJ)

Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, University of Western Australia Centre for Medical Research, Nedlands, WA, Australia.

Richa Saxena (R)

Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.
Departmentartment of Anesthesia, Critical Care and Pain Medicine, MGH, Boston, MA, USA.

Jeanette M Stafford (JM)

Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Beate St Pourcain (BS)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Nicholas J Timpson (NJ)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Perttu Salo (P)

Public Health Genomics Unit, Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland.

So-Youn Shin (SY)

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.

Najaf Amin (N)

Department of Epidemiology Erasmus MC, Rotterdam, the Netherlands.

Albert V Smith (AV)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
Icelandic Heart Association, Kopavogur, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Guo Li (G)

Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.
Department of Medicine, University of Washington, Seattle, WA, USA.

Niek Verweij (N)

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anuj Goel (A)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Ian Ford (I)

Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.

Paul C D Johnson (PCD)

Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Institute of Biodiversity, Animal Health & Comparative Medicine, University of Glasgow, Glasgow, UK.

Toby Johnson (T)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
NIHR Barts Cardiovascular Biomedical Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Karen Kapur (K)

Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland.

Gudmar Thorleifsson (G)

deCODE Genetics, Reykjavik, Iceland.

Rona J Strawbridge (RJ)

Cardiovascular Medicine Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Laura J Rasmussen-Torvik (LJ)

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Tõnu Esko (T)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Evelin Mihailov (E)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Tove Fall (T)

Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Ross M Fraser (RM)

Usher Institute, University of Edinburgh, Edinburgh, UK.
Synpromics Ltd, Roslin Innovation Centre, Easter Bush Campus, Edinburgh, EH25 9RG, UK.

Anubha Mahajan (A)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Genentech, 340 Point San Bruno Boulevard, South San Francisco, CA, 94080, USA.

Stavroula Kanoni (S)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Wellcome Trust Sanger Institute, Hinxton, UK.

Vilmantas Giedraitis (V)

Department of Public Health and Caring Sciences, Uppsala Universitet, Uppsala, Sweden.

Marcus E Kleber (ME)

Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Günther Silbernagel (G)

Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Julia Meyer (J)

Institute of Genetic Epidemiology,Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Martina Müller-Nurasyid (M)

Institute of Genetic Epidemiology,Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology and Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany.
Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI, University Medical Center, Johannes Gutenberg University, 55101, Mainz, Germany.

Andrea Ganna (A)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Antti-Pekka Sarin (AP)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Public Health Genomics Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

Loic Yengo (L)

University of Lille Nord de France, Lille, France.
CNRS UMR8199, Institut Pasteur de Lille, Lille, France.
Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Dmitry Shungin (D)

Department of Public Health & Clinical Medicine, Umeå University, Umeå, Sweden.
Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Malmö, Sweden.
Department of Odontology, Umeå University, Umeå, Sweden.

Jian'an Luan (J)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Momoko Horikoshi (M)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
RIKEN, Center for Integrative Medical Sciences, Laboratory for Endocrinology, Metabolism and Kidney Disease, Yokohama, Japan.

Ping An (P)

Division of Statistical Genomics, Washington University School of Medicine, St. Louis, MO, USA.

Serena Sanna (S)

Istituto di Ricerca Genetica e Biomedica, CNR, Monserrato, Italy.
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Yvonne Boettcher (Y)

Department of Medicine, University of Leipzig, Leipzig, Germany.
IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.

N William Rayner (NW)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Wellcome Trust Sanger Institute, Hinxton, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

Ilja M Nolte (IM)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Tatijana Zemunik (T)

Faculty of Medicine, University of Split, Split, Croatia.

Erik van Iperen (EV)

Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Peter Kovacs (P)

IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.

Nicholas D Hastie (ND)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Sarah H Wild (SH)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Stela McLachlan (S)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Susan Campbell (S)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Ozren Polasek (O)

Faculty of Medicine, University of Split, Split, Croatia.

Olga Carlson (O)

Laboratory of Clinical Investigation, National Institute of Aging, Baltimore, MD, USA.

Josephine Egan (J)

Laboratory of Clinical Investigation, National Institute of Aging, Baltimore, MD, USA.

Wieland Kiess (W)

IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.
Pediatric Research Center, Department of Women's & Child Health, University of Leipzig, Leipzig, Germany.

Gonneke Willemsen (G)

Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands.

Johanna Kuusisto (J)

Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Markku Laakso (M)

Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Maria Dimitriou (M)

Department of Dietetics-Nutrition, Harokopio University, Athens, Greece.

Andrew A Hicks (AA)

Center for Biomedicine, European Academy Bozen/Bolzano (EURAC) (Affiliated Institute of the University of LübeckLübeckGermany), Bolzano, Italy.

Rainer Rauramaa (R)

Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.

Stefania Bandinelli (S)

Geriatric Unit, Azienda Sanitaria Firenze (ASF), Florence, Italy.

Barbara Thorand (B)

German Center for Diabetes Research (DZD, München-Neuherberg, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Yongmei Liu (Y)

Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Iva Miljkovic (I)

Department of Epidemiology, Center for Aging and Population Health, University of Pittsburgh, Pittsburgh, PA, USA.

Lars Lind (L)

Department of Medical Sciences, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden.

Alex Doney (A)

Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.

Markus Perola (M)

Public Health Genomics Unit, Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland.
Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Estonian Genome Center, University of Tartu, Tartu, Estonia.

Aroon Hingorani (A)

Department of Epidemiology and Public Health, University College London, London, UK.

Mika Kivimaki (M)

Department of Epidemiology and Public Health, University College London, London, UK.

Meena Kumari (M)

Department of Epidemiology and Public Health, University College London, London, UK.
University of Essex, Wivenhoe Park, Colchester, Essex, UK.

Amanda J Bennett (AJ)

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

Christopher J Groves (CJ)

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

Christian Herder (C)

German Center for Diabetes Research (DZD, München-Neuherberg, Germany.
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Heikki A Koistinen (HA)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, P.O. Box 30, Helsinki, FI-00271, Finland.
Department of Medicine, University of Helsinki and Helsinki University Central Hospital, P.O. Box 340, Haartmaninkatu 4, Helsinki, FI-00029, Finland.
Minerva Foundation Institute for Medical Research, Biomedicum 2U, Tukholmankatu 8, Helsinki, FI-00290, Finland.

Leena Kinnunen (L)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, P.O. Box 30, Helsinki, FI-00271, Finland.

Ulf de Faire (U)

Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Stephan J L Bakker (SJL)

Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Matti Uusitupa (M)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Colin N A Palmer (CNA)

Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.

J Wouter Jukema (JW)

Dept of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Netherlands Heart Institute, Utrecht, the Netherlands.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Anneli Pouta (A)

Department of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland.
PEDEGO Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.

Harold Snieder (H)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Eric Boerwinkle (E)

IMM Center for Human Genetics, University of Texas Health Science Center at Houston, Houston, TX, USA.
Division of Epidemiology, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.

James S Pankow (JS)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MiI, USA.

Patrik K Magnusson (PK)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Ulrika Krus (U)

Department of Clinical Sciences, Diabetes and Endocrinology Research Unit, University Hospital Malmö, Lund University, Malmö, Sweden.

Chiara Scapoli (C)

Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.

Eco J C N de Geus (EJCN)

Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, VU University medical center, Amsterdam, the Netherlands.

Matthias Blüher (M)

Department of Medicine, University of Leipzig, Leipzig, Germany.
Department of Preventive Medicine, Keck School of Medicine of USC, Los Angeles, CA, USA.

Bruce H R Wolffenbuttel (BHR)

Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Michael A Province (MA)

Division of Statistical Genomics, Washington University School of Medicine, St. Louis, MO, USA.

Goncalo R Abecasis (GR)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

James B Meigs (JB)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
General Medicine Division, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

G Kees Hovingh (GK)

Department of Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
Novo Nordisk A/S, Copenhagen, Denmark.

Jaana Lindström (J)

Finnish Institute for Health and Welfare, Diabetes Prevention Unit, Helsinki, Finland.

James F Wilson (JF)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.
Usher Institute, University of Edinburgh, Edinburgh, UK.

Alan F Wright (AF)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

George V Dedoussis (GV)

Department of Dietetics-Nutrition, Harokopio University, Athens, Greece.

Stefan R Bornstein (SR)

Department of Medicine, Division for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Peter E H Schwarz (PEH)

Department for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Paul Langerhans Institute Dresden of the Helmholtz Center Munich at University Hospital and Faculty of Medicine, TU Dresden, Dresden, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Anke Tönjes (A)

Department of Medicine, University of Leipzig, Leipzig, Germany.
IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.

Bernhard R Winkelmann (BR)

Cardiology Group, Frankfurt-Sachsenhausen, Germany.

Bernhard O Boehm (BO)

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Imperial College London, Singapore, Singapore.

Winfried März (W)

Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany.

Andres Metspalu (A)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Jackie F Price (JF)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Panos Deloukas (P)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Wellcome Trust Sanger Institute, Hinxton, UK.
Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD, King Abdulaziz University, Jeddah, Saudi Arabia.

Antje Körner (A)

IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.
Diabetes Research Center, Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.

Timo A Lakka (TA)

Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
Institute of Biomedicine/Physiology, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.

Sirkka M Keinanen-Kiukaanniemi (SM)

Faculty of Medicine, Center for Life Course Health Research, University of Oulu, Oulu, Finland.
Unit of General Practice, Oulu University Hospital, Oulu, Finland.

Timo E Saaristo (TE)

Finnish Diabetes Association, Tampere, Finland.
Pirkanmaa Hospital District, Tampere, Finland.

Richard N Bergman (RN)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Jaakko Tuomilehto (J)

Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.
Centre for Vascular Prevention, Danube-University Krems, Krems, Austria.
Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Claudia Langenberg (C)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Satu Männistö (S)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, P.O. Box 30, Helsinki, FI-00271, Finland.

Paul W Franks (PW)

Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Malmö, Sweden.
Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
Department of Public Health & Clinical Medicine, Units of Medicine and Nutritional Research, Umeå University, Umeå, Sweden.

Caroline Hayward (C)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Veronique Vitart (V)

MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Jaakko Kaprio (J)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.

Sophie Visvikis-Siest (S)

Université de Lorraine, IGE-PCV, F-54000, Nancy, France.

Beverley Balkau (B)

Inserm, CESP Center for Research in Epidemiology and Public Health, U1018, Villejuif, France.
Univ Paris-Saclay, Univ Paris Sud, UVSQ, UMRS 1018, UMRS 1018, Villejuif, France.

David Altshuler (D)

Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Igor Rudan (I)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Michael Stumvoll (M)

Department of Medicine, University of Leipzig, Leipzig, Germany.
IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany.

Harry Campbell (H)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Cornelia M van Duijn (CM)

Genetic Epidemiology Unit, Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
Centre for Medical Systems Biology, Leiden, the Netherlands.

Christian Gieger (C)

Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.
German Center for Diabetes Research (DZD, München-Neuherberg, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Thomas Illig (T)

Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.
Hannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Institute of Human Genetics, Hannover Medical School, Hannover, Germany.

Luigi Ferrucci (L)

Clinical Research Branch, National Institute on Aging, Baltimore, Maryland, USA.

Nancy L Pedersen (NL)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Peter P Pramstaller (PP)

Center for Biomedicine, European Academy Bozen/Bolzano (EURAC) (Affiliated Institute of the University of LübeckLübeckGermany), Bolzano, Italy.
Department of Neurology, General Central Hospital, Bolzano, Italy.
Department of Neurology, University of Lübeck, Lübeck, Germany.

Michael Boehnke (M)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.

Timothy M Frayling (TM)

Genetics of Complex Traits, Peninsula Medical School, University of Exeter, Exeter, UK.

Alan R Shuldiner (AR)

Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA.
The Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Patricia A Peyser (PA)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Sharon L R Kardia (SLR)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Lyle J Palmer (LJ)

School of Public Health, University of Adelaide, Adelaide, Australia.

Brenda W Penninx (BW)

Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.

Pierre Meneton (P)

U872 Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, 75006, Paris, France.

Tamara B Harris (TB)

Geriatric Epidemiology Section, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD, USA.

Gerjan Navis (G)

Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Pim van der Harst (PV)

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

George Davey Smith (GD)

MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Ruth J F Loos (RJF)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Veikko Salomaa (V)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Nicole Soranzo (N)

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.

Dorret I Boomsma (DI)

Department of Biological Psychology, Vrije Universiteit, Amsterdam, the Netherlands.

Leif Groop (L)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Department of Clinical Sciences, Diabetes and Endocrinology Research Unit, University Hospital Malmö, Lund University, Malmö, Sweden.

Tiinamaija Tuomi (T)

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Department of Clinical Sciences, Diabetes and Endocrinology Research Unit, University Hospital Malmö, Lund University, Malmö, Sweden.
Endocrinology, Abdominal Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, University of Helsinki and Folkhälsan Research Center, Helsinki, Finland.

Albert Hofman (A)

Department of Epidemiology Erasmus MC, Rotterdam, the Netherlands.
Netherlands Consortium for healthy ageing, the Hague, the Netherlands.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.

Patricia B Munroe (PB)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
NIHR Barts Cardiovascular Biomedical Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Vilmundur Gudnason (V)

Icelandic Heart Association, Kopavogur, Iceland.
Faculty of Medicine University of Iceland, Reykjavik, Iceland.

David S Siscovick (DS)

Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.
Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Hugh Watkins (H)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Cecile Lecoeur (C)

University of Lille Nord de France, Lille, France.
CNRS UMR8199, Institut Pasteur de Lille, Lille, France.

Peter Vollenweider (P)

Department of Medicine, University Hospital Lausanne, Lausanne, Switzerland.

Anders Franco-Cereceda (A)

Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Per Eriksson (P)

Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Karolinska University Hospital, Solna, Sweden.

Marjo-Riitta Jarvelin (MR)

Department of Epidemiology and Biostatistics and HPA-MRC Center, School of Public Health, Imperial College London, London, UK.
Institue of Health Sciences, University of Oulu, Oulu, Finland.

Kari Stefansson (K)

deCODE Genetics, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavík, Iceland.

Anders Hamsten (A)

Cardiovascular Medicine Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
Department of Cardiology, Karolinska University Hospital Solna, Stockholm, Sweden.

George Nicholson (G)

Department of Statistics, University of Oxford, Oxford, UK.

Fredrik Karpe (F)

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, UK.

Emmanouil T Dermitzakis (ET)

Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.

Cecilia M Lindgren (CM)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.

Mark I McCarthy (MI)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Genentech, 340 Point San Bruno Boulevard, South San Francisco, CA, 94080, USA.

Philippe Froguel (P)

University of Lille Nord de France, Lille, France.
CNRS UMR8199, Institut Pasteur de Lille, Lille, France.
Department of Medicine, Imperial College London, London, UK.

Marika A Kaakinen (MA)

Department of Medicine, Imperial College London, London, UK.
School of Biosciences and Medicine, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.

Valeriya Lyssenko (V)

Department of Clinical Sciences, Diabetes and Endocrinology Research Unit, University Hospital Malmö, Lund University, Malmö, Sweden.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Richard M Watanabe (RM)

Department of Preventive Medicine, Keck School of Medicine of USC, Los Angeles, CA, USA.
Department of Physiology & Neuroscience, Keck School of Medicine of USC, Los Angeles, CA, USA.
USC Diabetes and Obesity Research Institute, Los Angeles, CA, USA.

Erik Ingelsson (E)

Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stanford Cardiovascular Institute, Stanford University, Stanford, CA, 94305, USA.

Jose C Florez (JC)

Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Diabetes Research Center, Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.

Josée Dupuis (J)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Inês Barroso (I)

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK.
Exeter Centre of ExcEllence in Diabetes (ExCEED), University of Exeter Medical School, Exeter, UK.

Andrew P Morris (AP)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Estonian Genome Center, University of Tartu, Tartu, Estonia.
Department of Biostatistics, University of Liverpool, Liverpool, UK.
Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.

Inga Prokopenko (I)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom. i.prokopenko@surrey.ac.uk.
Department of Medicine, Imperial College London, London, UK. i.prokopenko@surrey.ac.uk.
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK. i.prokopenko@surrey.ac.uk.
School of Biosciences and Medicine, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK. i.prokopenko@surrey.ac.uk.
Institute of Biochemistry and Genetics, Ufa Federal Research Centre Russian Academy of Sciences, Ufa, Russian Federation. i.prokopenko@surrey.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH